Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing

Vaccine

Volumn 34, Issue 17, 2016, Pages 2035-2043

  Mee, Edward T ^a   Preston, Mark D ^a   Minor, Philip D ^a   Schepelmann, Silke ^a   Huang, Xuening ^b   Nguyen, Jenny ^b   Wall, David ^b   Hargrove, Stacey ^b   Fu, Thomas ^b   Xu, George ^b   Li, Li ^b   Cote, Colette ^c   Delwart, Eric ^d,e   Li, Linlin ^d,e   Hewlett, Indira ^f   Simonyan, Vahan ^f   Ragupathy, Viswanath ^f   Voskanian Kordi, Alin ^f   Mermod, Nicolas ^g   Hill, Christiane ^h   Ottenwalder, Birgit ⁱ   Richter, Daniel C ⁱ   Tehrani, Arman ⁱ   Weber Lehmann, Jacqueline ^j   Cassart, Jean Pol ^j   Letellier, Carine ^j   Vandeputte, Olivier ^j   Ruelle, Jean Louis ^j   La Neve, Fabio ^k   Deyati, Avisek ^j   Modena, Chiara ^k   Mee, Edward ^a   Preston, Mark ^a   Minor, Philip ^a   Eloit, Marc ^l   Muth, Erika ^l   Lamamy, Arnaud ^l   Jagorel, Florence ^l   Cheval, Justine ^l   Anscombe, Catherine ^m   Misra, Raju ^m   Wooldridge, David ^m   Gharbia, Saheer ^m   Rose, Graham ^m   Ng, Siemon H S ⁿ   Charlebois, Robert L ⁿ   Gisonni Lex, Lucy ⁿ   Mallet, Laurent ⁿ   Dorange, Fabien ^o   Chiu, Charles ^e   Naccache, Samia ^e   Kellam, Paul ^p   van der Hoek, Lia ^p   Cotten, Matt ^p   Mitchell, Christine ^q   Baier, Brian S ^q   Sun, Wenping ^q   Malicki, Heather D ^q   more..

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b Advance Biosciences   (United States)

^c BioReliance   (United States)

^d BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^g UNIVERSITY OF LAUSANNE   (Switzerland)

^h Charles River Biopharmaceutical Services GmbH   (Germany)

ⁱ Eurofins Medinet Inc   (Germany)

^j GSK   (Belgium)

^k Merck Serono   (Italy)

^l Pathoquest   (France)

^m PUBLIC HEALTH ENGLAND   (United Kingdom)

ⁿ Sanofi Pasteur   (Canada)

^o Texcell   (France)

^p WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^q WuXiAppTecInc   (United States)

more..

Author keywords

Adventitious virus; Collaborative study; Deep sequencing; Reference material; Vaccine

Indexed keywords

BIOLOGICAL PRODUCT; REAGENT; REFERENCE MATERIAL; UNCLASSIFIED DRUG; VIRUS VACCINE; VACCINE;

ADENOVIRIDAE; ARTICLE; ASTROVIRIDAE; BIOINFORMATICS; CALICIVIRIDAE; CONTROLLED STUDY; CORONAVIRIDAE; DEEP SEQUENCING; EVALUATION STUDY; HERPESVIRIDAE; HIGH THROUGHPUT SEQUENCING; LABORATORY; NONHUMAN; ORTHOMYXOVIRIDAE; PARAMYXOVIRIDAE; PARECHOVIRUS; PICORNAVIRIDAE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REFERENCE VALUE; REOVIRIDAE; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; DRUG CONTAMINATION; ISOLATION AND PURIFICATION; PREVENTION AND CONTROL; STANDARD; STANDARDS; VIRUS;

BIOLOGICAL PRODUCTS; DRUG CONTAMINATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; LABORATORIES; REFERENCE STANDARDS; VACCINES; VIRUSES;

EID: 84960968448     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.12.020     Document Type: Article

References (35)

1. Victoria J.G., Wang C., Jones M.S., Jaing C., McLoughlin K., Gardner S., et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010, 84(Jun (12)):6033-6040. pii:JVI.02690-09. 10.1128/JVI. 02690-09.
2. Cutrone R., Lednicky J., Dunn G., Rizzo P., Bocchetta M., Chumakov K., et al. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res 2005, 65(Nov (22)):10273-10279. pii:65/22/10273. 10.1158/0008-5472.CAN-05-2028.
3. Gombold J., Karakasidis S., Niksa P., Podczasy J., Neumann K., Richardson J., et al. Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products. Vaccine 2014, 32(May (24)):2916-2926. pii:S0264-410X(14)00194-7. 10.1016/j.vaccine.2014.02.021.
4. Dubin G., Toussaint J.F., Cassart J.P., Howe B., Boyce D., Friedland L., et al. Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine. Rotarix: approach and outcome. Hum Vaccin Immunother 2013, 9(Nov (11)):2398-2408. pii:25973.
5. Gilliland S.M., Forrest L., Carre H., Jenkins A., Berry N., Martin J., et al. Investigation of porcine circovirus contamination in human vaccines. Biologicals 2012, 40(Jul (4)):270-277. pii:S1045-1056(12)00026-7. 10.1016/j.biologicals.2012.02.002.
6. Onions D., Cote C., Love B., Toms B., Koduri S., Armstrong A., et al. Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome. Vaccine 2011, 29(Sep (41)):7117-7121. pii:S0264-410X(11)00818-8. 10.1016/j.vaccine.2011.05.071.
7. McClenahan S.D., Uhlenhaut C., Krause P.R. Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing. Vaccine 2014, 32(Dec (52)):7115-7121. pii:S0264-410X(14)01385-1. 10.1016/j.vaccine.2014.10.022.
8. Onions D., Kolman J. Massively parallel sequencing, a new method for detecting adventitious agents. Biologicals 2010, 38(May (3)):377-380. pii:S1045-1056(10)00004-7. 10.1016/j.biologicals.2010.01.003.
9. Gagnieur L., Cheval J., Gratigny M., Hebert C., Muth E., Dumarest M., et al. Unbiased analysis by high throughput sequencing of the viral diversity in fetal bovine serum and trypsin used in cell culture. Biologicals 2014, 42(May (3)):145-152. pii:S1045-1056(14)00006-2. 10.1016/j.biologicals.2014.02.002.
10. Richards B., Cao S., Plavsic M., Pomponio R., Davies C., Mattaliano R., et al. Detection of adventitious agents using next-generation sequencing. PDA J Pharm Sci Technol 2014, 68(Nov (6)):651-660. pii:68/6/651. 10.5731/pdajpst.2014.01025.
11. Alfson K.J., Beadles M.W., Griffiths A. A new approach to determining whole viral genomic sequences including termini using a single deep sequencing run. J Virol Methods 2014, 208:1-5. pii:S0166-0934(14)00295-X. 10.1016/j.jviromet.2014.07.023.
12. Cotten M., Oude M.B., Canuti M., Deijs M., Watson S.J., Kellam P., et al. Full genome virus detection in fecal samples using sensitive nucleic acid preparation, deep sequencing, and a novel iterative sequence classification algorithm. PLOS ONE 2014, 9(4):e93269. pii:PONE-D-13-49127. 10.1371/journal.pone.0093269.
13. Hall R.J., Wang J., Todd A.K., Bissielo A.B., Yen S., Strydom H., et al. Evaluation of rapid and simple techniques for the enrichment of viruses prior to metagenomic virus discovery. J Virol Methods 2014, 195:194-204. pii:S0166-0934(13)00382-0. 10.1016/j.jviromet.2013.08.035.
14. Li L., Deng X., Mee E.T., Collot-Teixeira S., Anderson R., Schepelmann S., et al. Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent. J Virol Methods 2015, 213:139-146. pii:S0166-0934(14)00461-3. 10.1016/j.jviromet.2014.12.002.
15. Matranga C.B., Andersen K.G., Winnicki S., Busby M., Gladden A.D., Tewhey R., et al. Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples. Genome Biol 2014, 15(11):519. pii:s13059-014-0519-7. 10.1186/PREACCEPT-1698056557139770.
16. McClenahan S.D., Uhlenhaut C., Krause P.R. Optimization of virus detection in cells using massively parallel sequencing. Biologicals 2014, 42(Jan (1)):34-41. pii:S1045-1056(13)00134-6. 10.1016/j.biologicals.2013.11.002.
17. Moore N.E., Wang J., Hewitt J., Croucher D., Williamson D.A., Paine S., et al. Metagenomic analysis of viruses in feces from unsolved outbreaks of gastroenteritis in humans. J Clin Microbiol 2015, 53(Jan (1)):15-21. pii:JCM. 02029-14. 10.1128/JCM. 02029-14.
18. World Health Organization WHO Expert Committee on Biological Standardization sixty-fourth report 2013, www.who.int/en/.
19. McClenahan S.D., Krause P.R., Uhlenhaut C. Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011, 29(Jun (29-30)):4745-4753. pii:S0264-410X(11)00642-6. 10.1016/j.vaccine.04.087.
20. Naccache S.N., Greninger A.L., Lee D., Coffey L.L., Phan T., Rein-Weston A., et al. The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns. J Virol 2013, 87(Nov (22)):11966-11977. pii:JVI.02323-13. 10.1128/JVI. 02323-13.
21. Salter S.J., Cox M.J., Turek E.M., Calus S.T., Cookson W.O., Moffatt M.F., et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014, 12:87. pii:s12915-014-0087-z. 10.1186/s12915-014-0087-z.
22. Nelson M.C., Morrison H.G., Benjamino J., Grim S.L., Graf J. Analysis, optimization and verification of Illumina-generated 16S rRNA gene amplicon surveys. PLOS ONE 2014, 9(4):e94249. pii:PONE-D-13-49866. 10.1371/journal.pone.0094249.
23. Ng S.H., Azizi A., Edamura K., Malott R.J., Charlebois R.L., Logvinoff C., et al. Preliminary evaluation of next-generation sequencing performance relative to qPCR and in vitro cell culture tests for human cytomegalovirus. PDA J Pharm Sci Technol 2014, 68(Nov (6)):563-571. pii:68/6/563. 10.5731/pdajpst.2014.01013.
24. Naccache S.N., Federman S., Veeraraghavan N., Zaharia M., Lee D., Samayoa E., et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res 2014, 24(Jul (7)):1180-1192. pii:gr.171934.113. 10.1101/gr.171934.113.
25. Shamsaddini A., Pan Y., Johnson W.E., Krampis K., Shcheglovitova M., Simonyan V., et al. Census-based rapid and accurate metagenome taxonomic profiling. BMC Genomics 2014, 15:918. pii:1471-2164-15-918. 10.1186/1471-2164-15-918.
26. Wood D.E., Salzberg S.L. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol 2014, 15(3):R46. pii:gb-2014-15-3-r46. 10.1186/gb-2014-15-3-r46.
27. Segata N., Waldron L., Ballarini A., Narasimhan V., Jousson O., Huttenhower C. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods 2012, 9(Aug (8)):811-814. pii:nmeth.2066. 10.1038/nmeth.2066.
28. Brister J.R., Ako-Adjei D., Bao Y., Blinkova O. NCBI viral genomes resource. Nucleic Acids Res 2015, 43(Jan (Database issue)). pii:D571-D577.gku1207. 10.1093/nar/gku1207.
29. Maassab H.F. An infectious ribonucleic acid derived from influenza-infected cells. Proc Natl Acad Sci U S A 1959, 45(Jun (6)):877-881.
30. Alexander H.E., Koch G., Mountain I.M., Van D.O. Infectivity of ribonucleic acid from poliovirus in human cell monolayers. J Exp Med 1958, 108(Oct (4)):493-506.
31. Alexander H.E., Koch G., Mountain I.M., Sprunt K., Van D.O. Infectivity of ribonucleic acid of poliovirus on HeLa cell mono-layers. Virology 1958, 5(Feb (1)):172-173. pii:0042-6822(58)90014-X.
32. Cheval J., Sauvage V., Frangeul L., Dacheux L., Guigon G., Dumey N., et al. Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol 2011, 49(Sep (9)):3268-3275. pii:JCM. 00850-11. 10.1128/JCM. 00850-11.
33. Wang C.J., Feng S.F., Duncan P. Defining a sample preparation workflow for advanced virus detection and understanding sensitivity by next-generation sequencing. PDA J Pharm Sci Technol 2014, 68(Nov (6)):579-588. pii:68/6/579. 10.5731/pdajpst.2014.01010.
34. Frey K.G., Herrera-Galeano J.E., Redden C.L., Luu T.V., Servetas S.L., Mateczun A.J., et al. Comparison of three next-generation sequencing platforms for metagenomic sequencing and identification of pathogens in blood. BMC Genomics 2014, 15:96. pii:1471-2164-15-96. 10.1186/1471-2164-15-96.
35. Moore R.A., Warren R.L., Freeman J.D., Gustavsen J.A., Chenard C., Friedman J.M., et al. The sensitivity of massively parallel sequencing for detecting candidate infectious agents associated with human tissue. PLoS One 2011, 6(5):e19838. pii:PONE-D-10-06050. 10.1371/journal.pone.0019838.